Understanding Infant Bowel Movements: Breastfed Babies and Constipation

Breastfed infants tend to have more frequent bowel movements than formula-fed babies, but there is a wide range of normal variation. It is common for breastfed babies to have frequent bowel movements up to six weeks of age due to the gastro-colic reflex. However, it is also normal for breastfed babies to go several days without a bowel movement, sometimes up to 7-10 days. When a bowel movement does occur after a longer period of time, it may be a blow-out of normal consistency and should not cause concern as long as it appears painless.

It is important to note that simple straining to pass stool is also normal and doesn’t necessarily indicate constipation. However, if there are worrying signs such as difficulty with feeding, failure to gain weight, or signs of discomfort, medical attention should be sought.

It is not necessary to give a macrogol laxative unless a diagnosis of constipation is made. Additionally, introducing baby food containing fruit and vegetables is not appropriate for exclusively breastfed infants. Prune juice may help with constipation, but it is not recommended for infants until they are weaned at 4-6 months.

Overall, as long as the baby is well and examination is normal, there is no need for urgent referral to hospital. However, if constipation appears during the first few weeks of life, it may be a sign of a more serious condition such as Hirschsprung’s disease, which requires medical attention.

Using combined hormonal contraceptive pills (CHC) can be beneficial for women in their 40s and beyond. It can reduce menstrual bleeding and pain, as well as alleviate menopausal symptoms. CHC with levonorgestrel or norethisterone are recommended as they have a lower risk of venous thromboembolism compared to other progestogens. However, it is important to note that there are risks associated with CHC use, and women should be informed of these before deciding to use it. The Faculty of Sexual and Reproductive Health advises that CHC can be used until age 50, but after that, women should switch to non-hormonal methods as the risks of CHC generally outweigh the benefits. Women who wish to continue using CHC after age 50 should be assessed on an individual basis. Extended or continuous CHC regimens can also be used for contraception and to manage menstrual or menopausal symptoms. Additionally, CHC is associated with a reduced risk of ovarian and endometrial cancer that can last for several decades after stopping use. Finally, CHC may help maintain bone mineral density during the perimenopause compared to not using hormones.

Women over the age of 40 still require effective contraception until they reach menopause, despite a significant decline in fertility. The Faculty of Sexual and Reproductive Healthcare (FSRH) has produced specific guidance for this age group, titled Contraception for Women Aged Over 40 Years. No method of contraception is contraindicated by age alone, with all methods being UKMEC1 except for the combined oral contraceptive pill (UKMEC2 for women >= 40 years) and Depo-Provera (UKMEC2 for women > 45 years). The FSRH guidance provides specific considerations for each method, such as the use of COCP in the perimenopausal period to maintain bone mineral density and reduce menopausal symptoms. Depo-Provera use is associated with a small loss in bone mineral density, which is usually recovered after discontinuation. The FSRH also provides a table detailing how different methods may be stopped based on age and amenorrhea status. Hormone replacement therapy cannot be relied upon for contraception, and a separate method is needed. The FSRH advises that the POP may be used in conjunction with HRT as long as the HRT has a progestogen component, while the IUS is licensed to provide the progestogen component of HRT.

Recognizing Late Stage Dementia and the Importance of Advance Care Planning

Late stage dementia is characterized by a decline in physical and cognitive abilities, making it difficult for individuals to perform activities of daily living without assistance. Indicators of late stage dementia include urinary and fecal incontinence, inability to walk without assistance, and a lack of meaningful conversation. A Barthel score of less than three is also a sign of late stage dementia. Other signs include weight loss, urinary tract infections, severe pressure sores, recurrent fever, reduced oral intake, and aspiration pneumonia.

It is important to note that a Mini-Mental State examination score of less than 10 indicates severe dementia, but not necessarily that the patient is in decline towards death. However, it is crucial to discuss with dementia patients while they still have mental capacity how they would like the later stages of their care managed. Advance care planning can help ensure that their wishes are respected and that they receive the appropriate care and support during this difficult time.

Understanding Capacity to Make Decisions

Capacity to make decisions can vary and may change over time. A person who has the capacity to make one decision may not necessarily have the capacity to make another, and vice versa. To determine if a patient has the capacity to make a particular decision, they must understand the information given to them and be able to retain it long enough to weigh it and come to a decision for themselves. It is not necessary for a psychiatrist or psychogeriatrician to assess capacity, but seeking a specialist view may be helpful if there are doubts. Irrational decisions do not necessarily indicate a lack of capacity. Under the Mental Capacity Act 2005, an individual can appoint an attorney to make decisions on their behalf if they become mentally incapacitated in the future. The attorney can only make decisions when the patient has lost the capacity to make those decisions for themselves.

According to the guidelines of the Faculty of Sexual and Reproductive Health and the BNF, the recommended contraceptive method in this case is injectable progesterone. This method is not affected by drug interactions. However, as topiramate is an enzyme inducer, it can reduce the effectiveness of oestrogens and progesterone, which are components of combined contraceptive pills. Therefore, if a combined contraceptive pill is to be used, it should contain at least 50 micrograms of ethinyl estradiol. Barrier methods alone are not reliable and should not be used as the sole form of contraception. Progesterone-only pills and implants are not suitable due to the enhanced first pass metabolism of progesterone, which can result in decreased contraceptive efficacy.

Contraception for Women with Epilepsy

Women with epilepsy need to consider several factors when choosing a contraceptive method. The effectiveness of anti-epileptic medication can be affected by the contraceptive, and vice versa. Additionally, if a woman becomes pregnant while taking anti-epileptic medication, there is a risk of teratogenic effects on the fetus. To address these concerns, the Faculty of Sexual & Reproductive Healthcare (FSRH) recommends the consistent use of condoms in addition to other forms of contraception.

For women taking certain anti-epileptic medications such as phenytoin, carbamazepine, barbiturates, primidone, topiramate, and oxcarbazepine, the FSRH recommends using the combined oral contraceptive pill (COCP) or progestogen-only pill (POP) with a UK Medical Eligibility Criteria (UKMEC) rating of 3. The implant has a UKMEC rating of 2, while the Depo-Provera injection, intrauterine device (IUD), and intrauterine system (IUS) have a UKMEC rating of 1.

For women taking lamotrigine, the FSRH recommends using the COCP with a UKMEC rating of 3 or the POP, implant, Depo-Provera injection, IUD, or IUS with a UKMEC rating of 1. If a COCP is chosen, it should contain a minimum of 30 µg of ethinylestradiol.

In summary, women with epilepsy should carefully consider the potential interactions between their anti-epileptic medication and their chosen contraceptive method. Using condoms consistently in addition to other forms of contraception can help reduce the risk of unintended pregnancy and potential teratogenic effects on the fetus.

Understanding Pes Cavus and its Association with Genetic Diseases

Pes cavus, also known as claw foot, is a condition characterized by an excessively arched foot that gives an unnaturally high instep. This condition is often associated with genetic diseases such as Charcot-Marie-Tooth (CMT) disease and Friedreich’s ataxia.

Friedreich’s ataxia is an autosomal recessive condition that affects the nervous system. It is characterized by progressive limb and gait ataxia, dysarthria, loss of proprioception and vibration sense, absent tendon reflexes in the lower limbs, and extensor plantar responses. The disease can also lead to pes cavus and scoliosis due to muscle weakness, as well as cardiomyopathy. Unfortunately, the disease is often debilitating, with more than 95% of those affected being wheelchair-bound by the age of 45 and an average life expectancy of approximately 50.

On the other hand, CMT affects both motor and sensory nerves and is often first noticed in adolescence or early adulthood. Symptoms include weakness of the foot and lower leg muscles, which may result in foot drop and a characteristic high-stepped gait. Weakness of the small muscles in the feet can lead to deformities such as pes cavus. In addition, the lower legs may take on an ‘inverted champagne bottle’ appearance due to the loss of muscle bulk. Although the disease can progress to affect the hands, it is not considered fatal, and people with most forms of CMT have a normal life expectancy.

In summary, understanding the association between pes cavus and genetic diseases such as CMT and Friedreich’s ataxia is crucial in diagnosing and managing these conditions. While Friedreich’s ataxia can be debilitating and life-threatening, CMT is generally not fatal, but can still significantly impact a person’s quality of life.

Notifying the coroner is not legally required for this death, but it must be reported to the Local Authority Proper Officer under the Health Protection Regulations 2010.

Notifiable Deaths and Reporting to the Coroner

When it comes to death certification, certain deaths are considered notifiable and should be reported to the coroner. These include unexpected or sudden deaths, as well as deaths where the attending doctor did not see the deceased within 28 days prior to their passing (this was increased from 14 days during the COVID pandemic). Additionally, deaths that occur within 24 hours of hospital admission, accidents and injuries, suicide, industrial injury or disease, deaths resulting from ill treatment, starvation, or neglect, deaths occurring during an operation or before recovery from the effect of an anaesthetic, poisoning (including from illicit drugs), stillbirths where there is doubt as to whether the child was born alive, and deaths of prisoners or people in police custody are also considered notifiable.

It is important to note that these deaths should be reported to the coroner, who will then investigate the circumstances surrounding the death. This is to ensure that any potential criminal activity or negligence is properly addressed and that the cause of death is accurately determined. By reporting notifiable deaths to the coroner, we can help ensure that justice is served and that families receive the closure they need during a difficult time.

Managing Body Fluid Spillages

When it comes to managing body fluid spillages, hypochlorite is often recommended. This chlorine-based agent is typically used in granular or powder form and spread over the affected area. However, it’s important to note that chlorine-releasing agents can be hazardous if used in large volumes in confined spaces or mixed with urine. Adequate ventilation is crucial to ensure safety.

In addition to using hypochlorite, it’s recommended that staff wear personal protective equipment such as plastic aprons, gloves, masks, and eye protection when cleaning up body fluids. It’s also important to avoid using mops, as they can spread the contamination further.

Some NHS trusts recommend the use of Virkon, a multipurpose disinfectant that contains oxone, potassium peroxymonosulphate, sodium dodecylbenzenesulfonate, sulphamic acid, and inorganic buffers. Virkon is believed to be effective against HIV, hepatitis, and MRSA. By following these guidelines and using appropriate disinfectants, healthcare professionals can effectively manage body fluid spillages and minimize the risk of infection.

Endometrial cancer is associated with obesity, while cervical cancer is not.

Understanding Cervical Cancer and its Risk Factors

Cervical cancer is a type of cancer that affects the cervix, which is the lower part of the uterus. It is most commonly diagnosed in women under the age of 45, with the highest incidence rates occurring in those aged 25-29. The cancer can be divided into two types: squamous cell cancer and adenocarcinoma. Symptoms of cervical cancer may include abnormal vaginal bleeding, such as postcoital, intermenstrual, or postmenopausal bleeding, as well as vaginal discharge.

The most significant risk factor for cervical cancer is infection with the human papillomavirus (HPV), particularly serotypes 16, 18, and 33. Other risk factors include smoking, human immunodeficiency virus (HIV), early first intercourse, many sexual partners, high parity, and lower socioeconomic status. The mechanism by which HPV causes cervical cancer involves the production of oncogenes E6 and E7 by HPV 16 and 18, respectively. E6 inhibits the p53 tumour suppressor gene, while E7 inhibits the RB suppressor gene.

While the strength of the association between combined oral contraceptive pill use and cervical cancer is sometimes debated, a large study published in the Lancet in 2007 confirmed the link. It is important for women to undergo routine cervical cancer screening to detect any abnormalities early on and to discuss any potential risk factors with their healthcare provider.

Understanding Delusions: False Beliefs and Their Types

Delusions are false beliefs that individuals hold onto despite evidence to the contrary. These beliefs are often maintained by altering other beliefs to keep their entire belief system consistent. There are several types of delusions, including delusions of reference, control, paranoia, replacement, and guilt.

Delusions of reference involve the belief that something innocent in the public domain holds a special meaning for the individual. Delusions of control consist of the belief that an external force is controlling the patient, often citing electricity or radio waves as the mediator. Paranoid delusions involve the belief that people or organizations are plotting to harm or harass the patient, while delusions of replacement occur when someone in the patient’s life has been replaced by an impostor. Delusions of guilt involve feeling guilty or remorseful for no valid reason.

Understanding the different types of delusions can help individuals recognize when someone they know may be experiencing them. It is important to seek professional help if someone is experiencing delusions, as they can be a symptom of a larger mental health issue.

Stevens-Johnson Syndrome: A Severe Drug Reaction

Stevens-Johnson syndrome (SJS), also known as erythema multiforme major, is a severe and extensive drug reaction that always involves mucous membranes. This condition is characterized by the presence of blisters that tend to become confluent and bullous. One of the diagnostic signs of SJS is Nikolsky’s sign, which is the extension of blisters with gentle sliding pressure.

In addition to skin lesions, patients with SJS may experience systemic symptoms such as fever, prostration, cheilitis, stomatitis, vulvovaginitis, and balanitis. These symptoms can lead to difficulties with micturition. Moreover, SJS can affect the eyes, causing conjunctivitis and keratitis, which carry a risk of scarring and permanent visual impairment.

If there are lesions in the pharynx and larynx, it is important to seek an ENT opinion. SJS is a serious condition that requires prompt medical attention.

Key Terms in Epidemiology

Epidemiology is the study of the distribution and determinants of health and disease in populations. In this field, there are several key terms that are important to understand. An epidemic, also known as an outbreak, occurs when there is an increase in the number of cases of a disease above what is expected in a given population over a specific time period. On the other hand, an endemic refers to the usual or expected level of disease in a particular population. Finally, a pandemic is a type of epidemic that affects a large number of people across multiple countries, continents, or regions. Understanding these terms is crucial for epidemiologists to identify and respond to disease outbreaks and pandemics.

Vaccine Storage and Sensitivity

To maintain the potency and effectiveness of vaccines, it is important to store them properly. Vaccines can be sensitive to changes in temperature and exposure to light, which can reduce their shelf life and potency. Excessive heat can cause a decline in potency, while freezing can increase reactogenicity and reduce vaccine potency. Freezing can also lead to cracks in vaccine containers, which can result in contamination.

The nasal influenza vaccine should be stored between +2°C and +8°C and protected from light, similar to the intramuscular influenza vaccine. Refrigeration with close temperature monitoring is necessary to achieve this. However, the nasal influenza vaccine can be left out of the refrigerator for up to 12 hours before use, as long as it is not exposed to temperatures above 25°C. If it has not been used within 12 hours, it should be disposed of rather than re-refrigerated for future use. Proper vaccine storage is crucial to ensure their effectiveness and safety.

Chlamydia is best diagnosed using nucleic acid amplification tests (NAATs), which are highly sensitive and specific. In clinical practice, NAATs are the preferred method of testing. For females, vulvo-vaginal swabs are the most effective, while urethral swabs are typically used for men. Although cultures are also highly sensitive and specific, they can be less effective due to various factors such as inadequate specimen collection and overgrowth of cell cultures. Additionally, cell culture is expensive and requires experienced technicians. Patients who test positive for chlamydia should also be advised on the risks associated with unprotected sex and offered long-acting contraceptives. A pregnancy test may also be necessary.

Chlamydia is the most common sexually transmitted infection in the UK caused by Chlamydia trachomatis. It is often asymptomatic but can cause cervicitis and dysuria in women and urethral discharge and dysuria in men. Complications include epididymitis, pelvic inflammatory disease, and infertility. Testing is done through nuclear acid amplification tests (NAATs) on urine or swab samples. Screening is recommended for sexually active individuals aged 15-24 years. Doxycycline is the first-line treatment, but azithromycin may be used if contraindicated. Partners should be notified and treated.

Important Information about Tocilizumab Treatment

Tocilizumab is a medication used to treat severe rheumatoid arthritis and Covid-19 infection. However, it can lower the immune system’s ability to fight infections, increasing the risk of new or worsened infections. Additionally, it can suppress the C-Reactive Protein response for up to three months, making it a less reliable marker of infection.

It is important for GPs to be aware of these points for patients who have been treated in the hospital. Patients may be at an increased risk of infections, and signs of infection may be reduced. Therefore, increased vigilance is advised for timely detection of serious infections. Tocilizumab and sarilumab can also increase the risk of bowel perforation in people with diverticular disease.

Patients who have received tocilizumab treatment should avoid live vaccines for three months post-dose. If they are VZV IgG negative, they should avoid contact with anyone showing signs or symptoms of Chickenpox or shingles and seek medical advice if inadvertent exposure occurs. Women of childbearing potential must use effective contraception for three months after treatment.

Throat Swabs and Antibiotic Treatment for Sore Throat

Throat swabs are not always reliable in differentiating between infection and carriage, and their results take up to 48 hours to be reported. However, they may be useful in high-risk groups to guide treatment choices in case of treatment failure. Symptomatic treatment and a delayed prescription may be reasonable options for sore throat, but after three days, a prescription for antibiotics may be necessary. Penicillin V is the recommended antibiotic for a 10-day course, while erythromycin or clarithromycin should be given for 5 days if the patient is allergic to penicillin. Overall, careful consideration of the patient’s condition and risk factors is necessary in determining the appropriate treatment for sore throat.

Management of Idiopathic Thrombocytopenic Purpura in Children

Idiopathic thrombocytopenic purpura (ITP) is a self-limiting disorder that commonly occurs in children following an infection or immunization. Treatment is based on clinical symptoms rather than platelet count alone. In children with severe thrombocytopenia, who are often asymptomatic, avoiding antiplatelets and non-contact sports and reporting any change in symptoms urgently is recommended. Splenectomy is rarely indicated and only used in life-threatening bleeding or severe symptoms present for 12-24 months. High-dose dexamethasone is a second-line treatment used when first-line treatments, such as prednisolone, have failed. Platelet transfusions are rarely used in emergency management. Prednisolone is the first-line management if significant symptoms or a clinical need to raise the platelet count are present.

Authorisation for Administration of Routine Medicine

Authorisation for the administration of routine medicine can be granted by an individual who has parental responsibility for a child as defined by the Children Act 1989. However, in certain cases, it may not be clear whether the father has parental responsibility or if social services have taken on this role. For instance, if the parents are unmarried, the father can still have parental responsibility for the child as long as he is named on the birth certificate. It is important to clarify who has parental responsibility before administering any medication to a child. Proper authorisation must be obtained to ensure the safety and well-being of the child.

Soya milk may not be a suitable alternative for infants with cow’s milk protein allergy as many of them are also intolerant to it. Amino acid-based formula is the recommended management for severe cases or when extensive hydrolysed formula milk is ineffective.

Breastfeeding is encouraged if the mother eliminates cows milk proteins from her diet, but it may not be practical if she cannot produce enough milk for the child. For infants with mild to moderate cows milk protein allergy who are formula-fed, extensive hydrolysed milk formula is the first-line management.

Gastro-oesophageal reflux (GORD) may be managed with omeprazole or ranitidine, but only after a 1-2 week trial of alginate therapy. However, if the infant presents with persistent diarrhoea, cow’s milk protein allergy is a more likely diagnosis than GORD.

Cow’s milk protein intolerance/allergy (CMPI/CMPA) is a condition that affects approximately 3-6% of children and typically presents in formula-fed infants within the first 3 months of life. However, it can also occur in exclusively breastfed infants, although this is rare. Both immediate (IgE mediated) and delayed (non-IgE mediated) reactions can occur, with CMPA usually used to describe immediate reactions and CMPI for mild-moderate delayed reactions. Symptoms of CMPI/CMPA include regurgitation and vomiting, diarrhea, urticaria, atopic eczema, colic symptoms such as irritability and crying, wheezing, chronic cough, and rarely, angioedema and anaphylaxis.

Diagnosis of CMPI/CMPA is often based on clinical presentation, such as improvement with cow’s milk protein elimination. However, investigations such as skin prick/patch testing and total IgE and specific IgE (RAST) for cow’s milk protein may also be performed. If symptoms are severe, such as failure to thrive, referral to a pediatrician is necessary.

Management of CMPI/CMPA depends on whether the child is formula-fed or breastfed. For formula-fed infants with mild-moderate symptoms, extensive hydrolyzed formula (eHF) milk is the first-line replacement formula, while amino acid-based formula (AAF) is used for infants with severe CMPA or if there is no response to eHF. Around 10% of infants with CMPI/CMPA are also intolerant to soy milk. For breastfed infants, mothers should continue breastfeeding while eliminating cow’s milk protein from their diet. Calcium supplements may be prescribed to prevent deficiency while excluding dairy from the diet. When breastfeeding stops, eHF milk should be used until the child is at least 12 months old and for at least 6 months.

The prognosis for CMPI/CMPA is generally good, with most children eventually becoming milk tolerant. In children with IgE-mediated intolerance, around 55% will be milk tolerant by the age of 5 years, while in children with non-IgE mediated intolerance, most will be milk tolerant by the age of 3 years. However, a challenge is often performed in a hospital setting as anaphylaxis can occur.

Treatment Options for Enuresis: From Simple Measures to Medications

Enuresis, or bedwetting, is a common problem among children. While most children outgrow it, some may need treatment. The first step is to try simple measures such as restricting fluid intake and encouraging regular toilet use. If bedwetting persists, an enuresis alarm may be considered as first-line treatment. Desmopressin, a medication that reduces urine production, can be used for rapid control or in combination with an alarm. However, it should be used second line after an alarm has been tried. Desmopressin with an anticholinergic medication like oxybutynin is another option, but specialist assessment is recommended. Imipramine, a tricyclic antidepressant, may be considered as a last resort after all other treatments have failed and with caution due to potential side effects. Overall, treatment options for enuresis should be tailored to the individual child and their specific needs.

In most cases of acute, watery diarrhoea, stool cultures are not necessary, according to the current NICE CKS guidance. Treatment for gastroenteritis typically involves encouraging increased fluid intake and oral rehydration sachets, unless the patient is severely dehydrated. Stool specimens should only be sent if the patient is systemically unwell, has blood or pus in their stool, is immunocompromised, has a recent history of hospitalization or antibiotic treatment, has recently traveled to a foreign country outside of Western Europe, North America, Australia, or New Zealand, or if there is uncertainty about the diagnosis of gastroenteritis. Antibiotics are not typically recommended for healthy adults with acute diarrhoea of unknown cause.

Gastroenteritis can occur either at home or while traveling abroad, which is known as travelers’ diarrhea. This type of diarrhea is characterized by at least three loose to watery stools in 24 hours, along with abdominal cramps, fever, nausea, vomiting, or blood in the stool. The most common cause of traveler’s’ diarrhea is Escherichia coli. Another type of illness is acute food poisoning, which is caused by the ingestion of a toxin and results in sudden onset of nausea, vomiting, and diarrhea. Staphylococcus aureus, Bacillus cereus, and Clostridium perfringens are the typical causes of acute food poisoning.

Different infections have stereotypical histories and presentations. Escherichia coli is common among travelers and causes watery stools, abdominal cramps, and nausea. Giardiasis results in prolonged, non-bloody diarrhea. Cholera causes profuse, watery diarrhea and severe dehydration resulting in weight loss, but it is not common among travelers. Shigella causes bloody diarrhea, vomiting, and abdominal pain. Staphylococcus aureus causes severe vomiting with a short incubation period. Campylobacter usually starts with a flu-like prodrome and is followed by crampy abdominal pains, fever, and diarrhea, which may be bloody and may mimic appendicitis. Bacillus cereus has two types of illness: vomiting within six hours, typically due to rice, and diarrheal illness occurring after six hours. Amoebiasis has a gradual onset of bloody diarrhea, abdominal pain, and tenderness that may last for several weeks.

The incubation period for different infections varies. Staphylococcus aureus and Bacillus cereus have an incubation period of 1-6 hours, while Salmonella and Escherichia coli have an incubation period of 12-48 hours. Shigella and Campylobacter have an incubation period of 48-72 hours, while Giardiasis and Amoebiasis have an incubation period of more than seven days. The vomiting subtype of Bacillus cereus has an incubation period of 6-14 hours, while the diarrheal illness has an incubation period of more than six hours.

If a patient with COPD continues to smoke, it is not advisable to provide them with azithromycin prophylaxis. Instead, they should be offered smoking cessation. The use of high-dose inhaled corticosteroids is no longer recommended due to the increased risk of infections such as pneumonia. Long-term oral corticosteroids should only be used at low doses and on the advice of the respiratory team. Beta-carotene supplements are not recommended for the management of COPD due to limited evidence of their effectiveness.

The National Institute for Health and Care Excellence (NICE) updated its guidelines on the management of chronic obstructive pulmonary disease (COPD) in 2018. The guidelines recommend general management strategies such as smoking cessation advice, annual influenza vaccination, and one-off pneumococcal vaccination. Pulmonary rehabilitation is also recommended for patients who view themselves as functionally disabled by COPD.

Bronchodilator therapy is the first-line treatment for patients who remain breathless or have exacerbations despite using short-acting bronchodilators. The next step is determined by whether the patient has asthmatic features or features suggesting steroid responsiveness. NICE suggests several criteria to determine this, including a previous diagnosis of asthma or atopy, a higher blood eosinophil count, substantial variation in FEV1 over time, and substantial diurnal variation in peak expiratory flow.

If the patient doesn’t have asthmatic features or features suggesting steroid responsiveness, a long-acting beta2-agonist (LABA) and long-acting muscarinic antagonist (LAMA) should be added. If the patient is already taking a short-acting muscarinic antagonist (SAMA), it should be discontinued and switched to a short-acting beta2-agonist (SABA). If the patient has asthmatic features or features suggesting steroid responsiveness, a LABA and inhaled corticosteroid (ICS) should be added. If the patient remains breathless or has exacerbations, triple therapy (LAMA + LABA + ICS) should be offered.

NICE only recommends theophylline after trials of short and long-acting bronchodilators or to people who cannot use inhaled therapy. Azithromycin prophylaxis is recommended in select patients who have optimised standard treatments and continue to have exacerbations. Mucolytics should be considered in patients with a chronic productive cough and continued if symptoms improve.

Cor pulmonale features include peripheral oedema, raised jugular venous pressure, systolic parasternal heave, and loud P2. Loop diuretics should be used for oedema, and long-term oxygen therapy should be considered. Smoking cessation, long-term oxygen therapy in eligible patients, and lung volume reduction surgery in selected patients may improve survival in patients with stable COPD. NICE doesn’t recommend the use of ACE-inhibitors, calcium channel blockers, or alpha blockers

Treatment Options for Mild to Moderate Acne: Clindamycin, Lymecycline, Flucloxacillin, Minocycline, and Trimethoprim

Acne is classified as mild to moderate if there are less than 35 inflammatory lesions and less than 2 nodules. For this type of acne, topical clindamycin is recommended as a first-line treatment, which can be combined with benzoyl peroxide, adapalene, or tretinoin. On the other hand, oral lymecycline is not recommended for mild to moderate acne but is effective for moderate to severe acne. Flucloxacillin is not used in acne treatment, while minocycline is effective but can cause liver problems and a lupus-like syndrome. Lastly, trimethoprim is used for people with moderate to severe acne who cannot tolerate or have a contraindication to oral lymecycline or doxycycline. It is important to consult with a healthcare professional to determine the best treatment option for each individual case of acne.

In the early stages of vitiligo, the use of potent topical corticosteroids may be beneficial in reversing the changes. However, it is important to note that medications such as topical tacrolimus or oral steroids should only be prescribed by a dermatologist. Oral tacrolimus and topical miconazole are not effective in managing vitiligo, unless a fungal infection is suspected.

Understanding Vitiligo

Vitiligo is a medical condition that occurs when the immune system attacks and destroys melanocytes, leading to the loss of skin pigmentation. It is estimated to affect about 1% of the population, with symptoms typically appearing in individuals between the ages of 20 and 30 years. The condition is characterized by well-defined patches of depigmented skin, with the edges of the affected areas being the most prominent. Trauma to the skin may also trigger the development of new lesions, a phenomenon known as the Koebner phenomenon.

Vitiligo is often associated with other autoimmune disorders such as type 1 diabetes mellitus, Addison’s disease, autoimmune thyroid disorders, pernicious anemia, and alopecia areata. While there is no cure for vitiligo, there are several management options available. These include the use of sunblock to protect the affected areas of skin, camouflage make-up to conceal the depigmented patches, and topical corticosteroids to reverse the changes if applied early. Other treatment options may include topical tacrolimus and phototherapy, although caution is advised when using these treatments on patients with light skin. Overall, early diagnosis and management of vitiligo can help to improve the quality of life for affected individuals.

New Medical Driving Standards for Diabetes Patients

The medical driving standards for individuals with diabetes have recently changed. For those with a group 1 entitlement who are managed with tablets that carry the risk of inducing hypoglycaemia, they must stop driving and inform the DVLA if they have had more than one episode of severe hypoglycaemia within the preceding 12 months. Severe hypoglycaemia is defined as an episode that requires external help. In this case, the patient has experienced two episodes where external help from his wife was needed. As a result, the patient should cease driving until 12 months after the last but one episode and can only resume driving when stable control is demonstrated. These new standards aim to ensure the safety of both the driver and other individuals on the road.

Vaccination Contraindications

Vaccinations are generally safe and effective in preventing infectious diseases. However, certain conditions may raise concerns about the safety of immunisation. It is important to note that febrile convulsions, congenital heart disease, epilepsy in a sibling or first degree relative, and cystic fibrosis are not contraindications to vaccination.

Nevertheless, appropriate measures should be taken to prevent fever from occurring at the time of immunisation. Any concurrent febrile illness, on the other hand, contraindicates vaccination. It is crucial to consult with a healthcare provider to determine the best course of action for individuals with underlying medical conditions before receiving any vaccines. By doing so, we can ensure that everyone receives the necessary protection against preventable diseases.

Patients with bacterial vaginosis who have a history of clue cells can be treated with topical clindamycin as an alternative to metronidazole, according to the BNF. This is particularly useful for patients who are allergic to metronidazole.

Bacterial vaginosis (BV) is a condition where there is an overgrowth of anaerobic organisms, particularly Gardnerella vaginalis, in the vagina. This leads to a decrease in the amount of lactobacilli, which produce lactic acid, resulting in an increase in vaginal pH. BV is not a sexually transmitted infection, but it is commonly seen in sexually active women. Symptoms include a fishy-smelling vaginal discharge, although some women may not experience any symptoms at all. Diagnosis is made using Amsel’s criteria, which includes the presence of thin, white discharge, clue cells on microscopy, a vaginal pH greater than 4.5, and a positive whiff test. Treatment involves oral metronidazole for 5-7 days, with a cure rate of 70-80%. However, relapse rates are high, with over 50% of women experiencing a recurrence within 3 months. Topical metronidazole or clindamycin may be used as alternatives.

Bacterial vaginosis during pregnancy can increase the risk of preterm labor, low birth weight, chorioamnionitis, and late miscarriage. It was previously recommended to avoid oral metronidazole in the first trimester and use topical clindamycin instead. However, recent guidelines suggest that oral metronidazole can be used throughout pregnancy. The British National Formulary (BNF) still advises against using high-dose metronidazole regimens. Clue cells, which are vaginal epithelial cells covered with bacteria, can be seen on microscopy in women with BV.

This man is likely to have stage 3 chronic kidney disease (CKD). If an initial abnormal eGFR result is detected, it is important to conduct clinical assessment and repeat the test within 2 weeks to evaluate the rate of change in GFR. If CKD is confirmed, at least three eGFR assessments should be made over a period of not less than 90 days to monitor the rate of change in GFR. The frequency of eGFR monitoring will depend on the severity of kidney impairment. Significant progression of CKD is defined as a decline in eGFR of > 5 ml/min/1.73 m² within 1 year or >10 ml/min/1.73 m² within 5 years.

Proteinuria should be assessed by measuring the protein:creatinine or albumin:creatinine ratio, ideally on an early-morning urine specimen. Proteinuria (ACR ≥30 mg/mmol) together with haematuria may indicate glomerulonephritis and is an indication for referral. However, dipstick testing for haematuria is a screening tool that requires microscopy to make a definitive diagnosis. Haematuria is defined as >3 RBC/high power field of centrifuged sediment under the microscope. If there is only a trace, a sample needs to be sent to confirm haematuria. Patients with CKD should have their proteinuria level assessed at least annually.

To manage CKD, systolic blood pressure should be lowered to <140 mm Hg (target range 120-139 mmHg) and diastolic blood pressure to <90 mm Hg. Atorvastatin 20 mg should be offered for the primary or secondary prevention of CVD to people with CKD.

When a patient with poorly controlled diabetes presents with foot pain lasting more than a week, it is important to consider the possibility of Charcot joint. While septic arthritis should be ruled out in a hot swollen joint, this patient’s symptoms have persisted for several weeks, making septic arthritis less likely. Gout or pseudogout may also be considered, but typically affect the 1st MTPJ and are often recurrent. An anterior talo-fibular ligament tear could be a potential cause of forefoot pain and swelling, but would require a history of trauma. Ultimately, Charcot joint should be considered as a possible diagnosis in this patient.

Understanding Charcot Joints

A Charcot joint, also known as a neuropathic joint, is a condition where a joint becomes severely damaged due to a loss of sensation. While it was previously caused by syphilis, it is now commonly seen in diabetic patients. Despite the degree of joint disruption, Charcot joints are typically less painful than expected due to the sensory neuropathy. However, patients may still experience some degree of pain, with 75% reporting it. The joint is often swollen, red, and warm.

Charcot joints are characterized by extensive bone remodeling and fragmentation, particularly in the midfoot. This condition can cause significant disability and deformity if left untreated. Therefore, early diagnosis and management are crucial to prevent further damage and improve outcomes.

Patients between the ages of 40 and 90 are eligible to use FRAX.

Assessing Risk for Osteoporosis

Osteoporosis is a concern due to the increased risk of fragility fractures. To determine which patients are at risk and require further investigation, NICE produced guidelines in 2012. They recommend assessing all women aged 65 years and above and all men aged 75 years and above. Younger patients should be assessed if they have risk factors such as previous fragility fracture, current or frequent use of oral or systemic glucocorticoid, history of falls, family history of hip fracture, other causes of secondary osteoporosis, low BMI, smoking, and alcohol intake.

NICE suggests using a clinical prediction tool such as FRAX or QFracture to assess a patient’s 10-year risk of developing a fracture. FRAX estimates the 10-year risk of fragility fracture and is valid for patients aged 40-90 years. QFracture estimates the 10-year risk of fragility fracture and includes a larger group of risk factors. BMD assessment is recommended in some situations, such as before starting treatments that may have a rapid adverse effect on bone density or in people aged under 40 years who have a major risk factor.

Interpreting the results of FRAX involves categorizing the results into low, intermediate, or high risk. If the assessment was done without a BMD measurement, an intermediate risk result will prompt a BMD test. If the assessment was done with a BMD measurement, the results will be categorized into reassurance, consider treatment, or strongly recommend treatment. QFracture doesn’t automatically categorize patients into low, intermediate, or high risk, and the raw data needs to be interpreted alongside local or national guidelines.

NICE recommends reassessing a patient’s risk if the original calculated risk was in the region of the intervention threshold for a proposed treatment and only after a minimum of 2 years or when there has been a change in the person’s risk factors.